Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Incidence and Risk Factors for Early-Onset Hypertension after Allogeneic Hematopoietic Stem Cell Transplantation in Children

  • Kwon, Dae Hyun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Jung, Seungwon (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Lee, Eun-Jung (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Lee, Jae Young (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Moon, Sena (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Lee, Jae Wook (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Chung, Nack Gyun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Cho, Bin (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Kim, Hack Ki (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
  • Received : 2013.10.05
  • Accepted : 2013.10.23
  • Published : 2013.12.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: Survivors of pediatric hematopoietic stem cell transplantation (HSCT) are at risk for developing hypertension. The objectives of this study are to evaluate the prevalence and risk factors of early onset hypertension during the engraftment period after HSCT. Subjects and Methods: This is a retrospective study of 157 consecutive patients (mean age at HSCT: $9.1{\pm}5.1$ years) who underwent HSCT for acute myeloid leukemia (n=47), acute lymphoblastic leukemia (n=43), severe aplastic anemia (n=41), and other reasons (n=26). Blood pressure data were collected at five time points: 0, 7, 14, 21, and 28 days after HSCT. Hypertension was defined as having systolic and/or diastolic blood pressure ${\geq}95th$ percentile according to age, gender, and height. To analyze the risk factors related to hypertension, data, including patients' demographic and transplant characteristics, were reviewed. Results: Hypertension developed in 59 patients (38%), among whom 12 (7.6%) required long term therapy. Thirty-two (54%) patients had systolic and diastolic, 8 (14%) had only systolic, and 19 (32%) had only diastolic hypertension. Younger age, acute graft-versus-host disease, sinusoidal obstruction syndrome, treatment with antifungal agent, and greater increase in serum creatinine (Cr) levels were associated with hypertension. Multivariate analysis showed that younger age at HSCT and greater increase in serum Cr level were independent risk factors for hypertension. Conclusion: Prevalence of hypertension during immediate post-HSCT period is high, especially in younger children. A greater increase in Cr after HSCT was significantly associated with hypertension. Further study is needed to elucidate long-term cardiovascular complications in pediatric HSCT survivors.

Keywords

References

  1. Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 2007;109:1765-72. https://doi.org/10.1182/blood-2006-05-022335
  2. Majhail NS, Challa TR, Mulrooney DA, Baker KS, Burns LJ. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2009;15:1100-7. https://doi.org/10.1016/j.bbmt.2009.05.010
  3. Tichelli A, Passweg J, Wójcik D, et al. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica 2008; 93:1203-10. https://doi.org/10.3324/haematol.12949
  4. Hoffmeister PA, Hingorani SR, Storer BE, Baker KS, Sanders JE. Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010;16:515-24. https://doi.org/10.1016/j.bbmt.2009.11.018
  5. Kist-van Holthe JE, Bresters D, Ahmed-Ousenkova YM, et al. Long-term renal function after hemopoietic stem cell transplantation in children. Bone Marrow Transplant 2005;36:605-10. https://doi.org/10.1038/sj.bmt.1705110
  6. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007;49:69-75. https://doi.org/10.1161/01.HYP.0000252676.46043.18
  7. McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 2007;150:640-4, 644.e1. https://doi.org/10.1016/j.jpeds.2007.01.052
  8. Redwine KM, Acosta AA, Poffenbarger T, Portman RJ, Samuels J. Development of hypertension in adolescents with pre-hypertension. J Pediatr 2012;160:98-103. https://doi.org/10.1016/j.jpeds.2011.07.010
  9. Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology. Circulation 2000;101:329-35. https://doi.org/10.1161/01.CIR.101.3.329
  10. Onusko E. Diagnosing secondary hypertension. Am Fam Physician 2003; 67:67-74.
  11. Kist-van Holthe JE, van Zwet JM, Brand R, van Weel MH, Vossen JM, van der Heijden AJ. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 1998;22:559-64. https://doi.org/10.1038/sj.bmt.1701388
  12. Esiashvili N, Chiang KY, Hasselle MD, Bryant C, Riffenburgh RH, Paulino AC. Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol 2009;90:242-6. https://doi.org/10.1016/j.radonc.2008.09.017
  13. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2 Suppl 4th Report): 555-76. https://doi.org/10.1542/peds.114.2.S2.555
  14. Shapiro DJ, Hersh AL, Cabana MD, Sutherland SM, Patel AI. Hypertension screening during ambulatory pediatric visits in the United States, 2000-2009. Pediatrics 2012;130:604-10. https://doi.org/10.1542/peds.2011-3888
  15. Lo JC, Sinaiko A, Chandra M, et al. Prehypertension and hypertension in community-based pediatric practice. Pediatrics 2013;131:e415-24. https://doi.org/10.1542/peds.2012-1292
  16. Boucek MM, Waltz DA, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric heart transplantation report--2006. J Heart Lung Transplant 2006;25: 893-903. https://doi.org/10.1016/j.healun.2006.05.014
  17. Sinha MD, Kerecuk L, Gilg J, Reid CJ; British Association for Paediatric Nephrology. Systemic arterial hypertension in children following renal transplantation: prevalence and risk factors. Nephrol Dial Transplant 2012;27:3359-68. https://doi.org/10.1093/ndt/gfr804
  18. Armenian SH, Sun CL, Vase T, et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood 2012;120:4505-12. https://doi.org/10.1182/blood-2012-06-437178
  19. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002;2:807-18. https://doi.org/10.1034/j.1600-6143.2002.20902.x
  20. Roche SL, Kaufmann J, Dipchand AI, Kantor PF. Hypertension after pediatric heart transplantation is primarily associated with immunosuppressive regimen. J Heart Lung Transplant 2008;27:501-7. https://doi.org/10.1016/j.healun.2008.01.018
  21. Panoulas VF, Douglas KM, Stavropoulos-Kalinoglou A, et al. Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. Rheumatology (Oxford) 2008;47:72-5. https://doi.org/10.1093/rheumatology/kem311
  22. Hingorani SR, Guthrie K, Batchelder A, et al. Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Kidney Int 2005;67:272-7. https://doi.org/10.1111/j.1523-1755.2005.00078.x
  23. Ventura HO, Mehra MR, Stapleton DD, Smart FW. Cyclosporine-induced hypertension in cardiac transplantation. Med Clin North Am 1997;81: 1347-57. https://doi.org/10.1016/S0025-7125(05)70587-3
  24. Izumi N, Furukawa T, Sato N, et al. Risk factors for acute graft-versushost disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A. Bone Marrow Transplant 2007;40:875-80. https://doi.org/10.1038/sj.bmt.1705834
  25. Singer DR, Jenkins GH. Hypertension in transplant recipients. J Hum Hypertens 1996;10:395-402.
  26. Wehbe E, Duncan AE, Dar G, Budev M, Stephany B. Recovery from AKI and short- and long-term outcomes after lung transplantation. Clin J Am Soc Nephrol 2013;8:19-25. https://doi.org/10.2215/CJN.04800512

Cited by

  1. Differentiation of induced pluripotent stem cell–derived neutrophil granulocytes from common marmoset monkey (Callithrix jacchus) vol.57, pp.1, 2013, https://doi.org/10.1111/trf.13909
  2. Radiotherapy, chemotherapy and atherosclerosis vol.32, pp.4, 2013, https://doi.org/10.1097/hco.0000000000000404
  3. Early and late complications following hematopoietic stem cell transplantation in pediatric patients – A retrospective analysis over 11 years vol.13, pp.10, 2018, https://doi.org/10.1371/journal.pone.0204914
  4. Comparison of blood pressure values and expression of genes associated with hypertension in children before and after hematopoietic cell transplantation vol.11, pp.1, 2013, https://doi.org/10.1038/s41598-021-88848-7